Anti-Fibroblast activation protein, alpha antibody (Ab53066)
Prolyl endopeptidase FAP, 170 kDa melanoma membrane-bound gelatinase, Dipeptidyl peptidase FAP, Fibroblast activation protein alpha, Gelatine degradation protease FAP, Integral membrane serine protease, Post-proline cleaving enzyme, Serine integral membrane protease, Surface-expressed protease, FAPalpha, SIMP, Seprase, FAP
详细信息
特异性
ab53066 detects endogenous levels of total Fibroblast activation protein, alpha. Please note the immunogen used to produce this product has 92% homology with Mouse DPPIV/CD26.
背景信息
Anti-Fibroblast activation protein, alpha (FAP) antibody (ab53066) is a rabbit polyclonal antibody and is validated for use in IHC-P, WB in human, mouse, rabbit samples. Anti-Fibroblast activation protein, alpha antibody (ab53066) has been cited over 134 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-Fibroblast activation protein, alpha antibody (ab53066) has high sensitivity and specificity. Anti-Fibroblast activation protein, alpha antibody (ab53066) has 13 independent reviews from customers. Anti-Fibroblast activation protein, alpha antibody (ab53066) specifically detects Fibroblast activation protein, alpha (UniProt ID: Q12884; Molecular weight: 88kDa) and is sold in 100 µg selling sizes. Fibroblast activation protein (FAP) is a type II transmembrane serine protease predominantly expressed in cancer-associated fibroblasts (CAFs) within the tumor microenvironment. Fibroblast activation protein (FAP) plays a crucial role in remodeling the extracellular matrix, promoting tumor growth, invasion, and metastasis. It is minimally expressed in normal tissues but significantly upregulated in various cancers, making it a potential biomarker for malignancy.
文献引用 (147)
Viscoelastic hydrogel primed CAR-macrophage for pulmonary fibrosis treatment.
粘弹性水凝胶预处理的CAR-巨噬细胞用于肺纤维化治疗。
Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer.
识别程序性细胞死亡相关亚型揭示了结肠癌的免疫异质性和治疗差异。
Dual Targeting of FAP-Directed Nanoparticles and FRα-Specific CAR-T Cells Induces Additive Anti-Tumor Effects in Triple-Negative Breast Cancer.
FAP靶向纳米颗粒和FRα特异性CAR-T细胞的双重靶向作用可对三阴性乳腺癌产生叠加的抗肿瘤效应。
Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer.
成纤维细胞活化蛋白α靶向纳米颗粒用于三阴性乳腺癌肿瘤微环境重塑和抗肿瘤治疗。
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?
从实验室到临床,再到手术刀,最终回归实验室:FAP在青少年血管纤维瘤中的表达。对FAPI-PET/CT成像和靶向治疗的潜在意义?
A new (68)Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancer.
一种新型 (68)Ga 标记的二聚体 FAP 配体,用于推进癌症的靶向 PET 成像。
Combined antitumor activity of [(177)Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.
[(177)Lu]Lu-FAPI-2286 和帕唑帕尼在肉瘤模型中的联合抗肿瘤活性:一项针对成纤维细胞活化蛋白的临床前治疗诊断研究。
HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity.
HMGA2 和蛋白质亮氨酸甲基化驱动胰腺癌谱系可塑性
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
HMGA2表达可预测胰腺导管腺癌的亚型、生存期和治疗结果
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.
抗FAP CAR-NK细胞作为一种新型靶向疗法,用于治疗宫颈癌和癌相关成纤维细胞。
- 1
- 2
- 3
- 4
- 5
- 6
- 15